GlassScriptPhysician profile
Ahmed Khan
NPI 1114303070
$3,456.29
in general payments reported to CMS, 2019-2025
10 companies · $336 in 2025
The $336 reported for 2025 was more than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64.36 · 2022: $440 · 2023: $1,908 · 2024: $708 · 2025: $336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,779 · Travel and Lodging: $1,173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,778.73 |
| Travel and Lodging | $1,173.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $1,667.45 | 2023-2024 | Indigo System |
| Sirtex Medical INC | $445.45 | 2023-2024 | Sir-Spheres Microspheres |
| Abbott Laboratories | $399.01 | 2023-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Imperative Care, INC | $320.19 | 2024-2025 | Symphony Catheter, Prodigy Catheter |
| Zimvie INC. | $269.24 | 2022 | |
| Medtronic, INC. | $164.61 | 2022-2023 | Abre |
| Novartis Pharmaceuticals Corporation | $64.36 | 2019 | |
| Nevro Corp. | $54.30 | 2024 | Senza |
| Trisalus Life Sciences, INC. | $44.81 | 2025 | Trinav Infusion System |
| Janssen Pharmaceuticals, INC | $26.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmed Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.